Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb 14;7(1):e12119.
doi: 10.1002/trc2.12119. eCollection 2021.

Herpesvirus infections, antiviral treatment, and the risk of dementia-a registry-based cohort study in Sweden

Affiliations

Herpesvirus infections, antiviral treatment, and the risk of dementia-a registry-based cohort study in Sweden

Karin Lopatko Lindman et al. Alzheimers Dement (N Y). .

Abstract

Introduction: Herpesviruses, including Herpes simplex virus type 1 (HSV1) and varicella zoster-virus (VZV), have been implicated in Alzheimer's disease (AD) development. Likewise, antiviral treatment has been suggested to protect against dementia development in herpes-infected individuals.

Methods: The study enrolled 265,172 subjects aged ≥ 50 years, with diagnoses of VZV or HSV, or prescribed antiviral drugs between 31 December 2005 and 31 December 2017. Controls were matched in a 1:1 ratio by sex and birth year.

Results: Antiviral treatment was associated with decreased risk of dementia (adjusted hazard ratio [HR] 0.89, 95% confidence interval [CI] 0.86 to 0.92), while herpes infection without antiviral drugs increased the risk of dementia (adjusted HR 1.50, 95% CI 1.29 to 1.74).

Discussion: Antiviral treatment was associated with a reduced long-term risk of dementia among individuals with overt signs of herpes infection. This is consistent with earlier findings indicating that herpesviruses are involved in the pathogenesis of AD.

Keywords: Alzheimer's disease; antiviral agents; dementia; herpes simplex; herpes zoster; retrospective cohort study; varicella zoster.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Kaplan‐Meier curve of the cumulative incidence of dementia in different groups. “Controls 1” denote controls of the “Herpes, no treatment” group. “Controls 2” denote controls of the “Herpes, with treatment” group. The follow‐up differentiated between subjects, but censors were not drawn in the diagram due to the high number of individuals censored at each time point

Similar articles

Cited by

References

    1. Itzhaki RF, Lathe R, Balin BJ, et al. Microbes and Alzheimer's Disease. J Alzheimers Dis. 2016;51:979‐984. - PMC - PubMed
    1. Harris SA, Harris EA. Herpes simplex virus Type 1 and other pathogens are key causative factors in sporadic Alzheimer's disease. J Alzheimers Dis. 2015;48:319‐353. - PMC - PubMed
    1. Steel AJ, Eslick GD. Herpes viruses increase the risk of Alzheimer's disease: a meta‐analysis. J Alzheimers Dis. 2015;47:351‐364. - PubMed
    1. Lovheim H, Gilthorpe J, Adolfsson R, Nilsson LG, Elgh F. Reactivated herpes simplex infection increases the risk of Alzheimer's disease. Alzheimer's Dement. 2015;11:593‐599. - PubMed
    1. Lovheim H, Gilthorpe J, Johansson A, Eriksson S, Hallmans G, Elgh F. Herpes simplex infection and the risk of Alzheimer's disease: a nested case‐control study. Alzheimer's Dement. 2015;11:587‐592. - PubMed

LinkOut - more resources